Next Article in Journal / Special Issue
Building and Testing PPARγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain
Previous Article in Journal
Citrus Auraptene Induces Expression of Brain-Derived Neurotrophic Factor in Neuro2a Cells
Previous Article in Special Issue
Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
Open AccessFeature PaperArticle

Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARγ Agonist via a Combined Computational and Functional Study

1
Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), 80078 Pozzuoli (NA), Italy
2
Endocannabinoid Research Group (ERG), Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy
3
Department of Pharmacy, University of Naples “Federico II”, Via D. Montesano 49, I-80131 Napoli, Italy
4
Dipartimento di Scienze del Farmaco, Università del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy
*
Authors to whom correspondence should be addressed.
Molecules 2020, 25(5), 1119; https://doi.org/10.3390/molecules25051119
Received: 30 January 2020 / Revised: 28 February 2020 / Accepted: 1 March 2020 / Published: 3 March 2020
(This article belongs to the Special Issue Role of PPAR Receptors in Human Health and Disease)
Phytocannabinoids (pCBs) are a large family of meroterpenoids isolated from the plant Cannabis sativa. Δ9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best investigated phytocannabinoids due to their relative abundance and interesting bioactivity profiles. In addition to various targets, THC and CBD are also well-known agonists of peroxisome proliferator-activated receptor gamma (PPARγ), a nuclear receptor involved in energy homeostasis and lipid metabolism. In the search of new pCBs potentially acting as PPARγ agonists, we identified cannabimovone (CBM), a structurally unique abeo-menthane pCB, as a novel PPARγ modulator via a combined computational and experimental approach. The ability of CBM to act as dual PPARγ/α agonist was also evaluated. Computational studies suggested a different binding mode toward the two isoforms, with the compound able to recapitulate the pattern of H-bonds of a canonical agonist only in the case of PPARγ. Luciferase assays confirmed the computational results, showing a selective activation of PPARγ by CBM in the low micromolar range. CBM promoted the expression of PPARγ target genes regulating the adipocyte differentiation and prevented palmitate-induced insulin signaling impairment. Altogether, these results candidate CBM as a novel bioactive compound potentially useful for the treatment of insulin resistance-related disorders. View Full-Text
Keywords: phytocannabinoids; cannabimovone (CBM); peroxisome proliferator-activated receptor gamma (PPARγ); molecular docking; molecular dynamics; insulin resistance phytocannabinoids; cannabimovone (CBM); peroxisome proliferator-activated receptor gamma (PPARγ); molecular docking; molecular dynamics; insulin resistance
Show Figures

Graphical abstract

MDPI and ACS Style

Iannotti, F.A.; De Maio, F.; Panza, E.; Appendino, G.; Taglialatela-Scafati, O.; De Petrocellis, L.; Amodeo, P.; Vitale, R.M. Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARγ Agonist via a Combined Computational and Functional Study. Molecules 2020, 25, 1119. https://doi.org/10.3390/molecules25051119

AMA Style

Iannotti FA, De Maio F, Panza E, Appendino G, Taglialatela-Scafati O, De Petrocellis L, Amodeo P, Vitale RM. Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARγ Agonist via a Combined Computational and Functional Study. Molecules. 2020; 25(5):1119. https://doi.org/10.3390/molecules25051119

Chicago/Turabian Style

Iannotti, Fabio A.; De Maio, Fabrizia; Panza, Elisabetta; Appendino, Giovanni; Taglialatela-Scafati, Orazio; De Petrocellis, Luciano; Amodeo, Pietro; Vitale, Rosa M. 2020. "Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARγ Agonist via a Combined Computational and Functional Study" Molecules 25, no. 5: 1119. https://doi.org/10.3390/molecules25051119

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop